Skip to content
Abierto
Menu

Award notice, first published as solicitation

Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials

HT942524Q0107

Defense Health Agency (Dha), Army Med Res Acq Activity. Medicinal and Botanical Manufacturing.

View on SAM.govMarkdown

Awarded

Sigma-Aldrich, Inc.

$1,249,000.00 on the award notice, September 20, 2024, contract HT942524P0161

Description

As published on SAM.gov.

Manufacturing of Army Lipsome Formulation Containing QS-21 (AFLQ) under current Good Manufacturing Practices (cGMP)

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Sigma-Aldrich, Inc.
UEI
WFYWL6SQ6FB8
CAGE
54968
Vendor location
Saint Louis, MO
Contract
HT942524P0161, purchase order
Obligated
$0.00
Actions
3 between September 20, 2024 and August 12, 2025
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
Manufacturing of Army Liposome Formulation for Clinical Trails Phase 2 and 3 for Walter Reed Army Institute of Research.
Match
award number HT942524P0161 equals the contract number; same awarding office HT9425 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 23, 2024

    Solicitation

    Due August 23, 2024 at 11:00 AM EDT. SAM.gov, notice ce93dac94ccf4e518c6d92eeed697989

  2. August 14, 2024

    Solicitation

    Due August 23, 2024 at 11:00 AM EDT. SAM.gov, notice 241908575f854fb3b47dee0c6f2ae033

  3. August 15, 2024

    Solicitation

    Due August 23, 2024 at 11:00 AM EDT. SAM.gov, notice d1dac756701e4a68a735cc5e4bd141d9

  4. September 25, 2024

    Award notice, originally solicitation

    Awarded to SIGMA-ALDRICH, Inc. Saint Louis for $1,249,000. SAM.gov, notice e7be774592a244d898f1a384df1c5ff9

Points of contact

Also open from this buyer